Longevity

Our Mission to Help Cure Long Covid

On Demand Therapeutic Plasma Exchange

The advent of COVID-19 pandemic has increased long COVID incidence, a significant public health issue.

How Does Therapeutic Plasma Exchange Help Long COVID Patients?


Long COVID refers to a range of persistent symptoms and health issues that can occur after the acute phase of a COVID-19 infection. These symptoms may include fatigue, brain fog, shortness of breath, joint pain, and others. It's important to note that long COVID is a complex condition, and its underlying mechanisms are not yet fully understood.

In some cases, individuals with long COVID may develop autoimmune-related complications, such as autoimmune encephalitis or vasculitis, which involve the immune system mistakenly attacking the body's own tissues. TPE has been used as a treatment modality in certain autoimmune conditions to remove autoantibodies and inflammatory mediators from the plasma, aiming to alleviate symptoms and improve overall health. TPE has been used in some cases to manage certain symptoms and complications associated with the condition.

Meet our Team

Dedrick Jacobi
CEO, Founder and Director
Jocelyn Bruen
CEO, Founder and Director
Keith Casper
CEO, Founder and Director

Resources

Therapeutic plasma exchange (TPE) and blood products – Implications for longevity and disease

icon-document

View Research

May 2, 2023